Institute events
RSS feed“1000 researchers in schools” – November 8-December 3
This year, the 9th edition of the scientific information operation for 3rd year and high school students “1000 researchers in schools in France and abroad” will take place between November 8 and December 3. The 8 previous editions gave rise to just over 8,000 interventions by the scientific experts of the AFM-Telethon throughout France, for … [Read more]
Advances in research : two new documents are available
« Advances in Steinert’s disease » and « Advances in myotonic dystrophy type 2 » are two new documents, published by the French Muscular Dystrophy Association (AFM-Téléthon), which can be downloaded. Steinert’s disease or myotonic dystrophy type 1 is a rare disease of genetic origin. It affects the muscles, which become weak (dystrophy) and … [Read more]
Assessment of energy metabolism and blood flow by NMR during and after exercise
Interview with Alfredo Lopez Kolkovsky, researcher from the NMR Imaging and Spectroscopy Laboratory at the Neuromuscular Investigation Centre of the Institute of Myology, jointly managed by H. Reyngoudt and B. Marty. He is the first author of an article* published in the journal Magnetic Resonance in Medicine on the assessment of energy metabolism and blood flow by … [Read more]
WMS 2021: Clinicians and researchers from the Institute mobilized for this new edition
From September 20 to 24, the 26th International Congress of the World Muscle Society (WMS), bringing together muscle experts from around the world, will highlight the work of numerous researchers and clinicians from the Institute of Myology. From basic research, through clinical trials, to therapeutic advances, no less than 32 communications (3 oral presentations and … [Read more]
M&M’s – Muscle Monday Seminar – 13 September – Charlotte A. Peterson (UK)
Novel roles for satellite cells in muscle adaptation and aging Monday September 13th 2021 from 4pm to 5pm Charlotte A. Peterson (Joseph Hamburg Endowed Professor, Director of the Center for Muscle Biology, UK College of Health Science) On prior registration for people outside the Institute of Myology: medecine-umrs974-myologie@sorbonne-universite.fr More information on the presentation and the speaker … [Read more]
Hope, an exceptional dance gala for the benefit of research excellence
On October 21, at 8:30 p.m., the Casino de Paris will host an exceptional show for the benefit of the Institute of Myology, a research and care center of excellence created by the AFM-Telethon and dedicated to Muscle science and medicine. At the initiative of Laura Arend, dancer and choreographer, and Charlotte Ranson, dancer … [Read more]
M&M’s – Muscle Monday Seminar – 6 September – Adam J. Engler (USA)
Age-dependent Cardiac Dysfunction as a Mechanical Disease Monday September 6th 2021 from 4pm to 5pm Adam J. Engler (Professor and Vice-Chair of Bioengineering at UC San Diego, Resident scientist at the Sanford Consortium for Regenerative Medicine, Associate Director of the Medical-Scientist Training Program (MSTP)) On prior registration for people outside the Institute of Myology: medecine-umrs974-myologie@sorbonne-universite.fr > … [Read more]
Release of the 86th newsletter from the Institute – July 2021
Prof. Fabrice Chrétien joined the teams of the Institute of Myology on June 15 as Director of the Center for Neuromuscular Exploration and Assessment which is currently composed by a staff of thirty persons. It encompasses three laboratories and a tissue bank: the Neuromuscular Physiology and Evaluation Laboratory, the NMR and Spectroscopy Laboratory, the Morphological Unit and the biological … [Read more]
Appointment of Piera Smeriglio at the head of BOND group
Piera Smeriglio will take over the management of the BOND Group – Biotherapies for motor neuron disorders (ALS & SMA) following the upcoming departure of Maria Grazia Biferi to whom we send our best wishes and whom we warmly thank for the work she has done with her group within the framework of the Myology … [Read more]
DMD: start at I-Motion of trials with pamrevlumab in ambulatory and non-ambulatory patients
I-Motion is recruiting patients with Duchenne muscular dystrophy to participate in two pharmacological trials designed to test an antifibrotic monoclonal antibody, pamrevlumab (or FG-3019), developed by FibroGen. The objective of these phase III trials is to assess the tolerance, safety and efficacy on the upper limbs, respiratory and cardiac functions of pamrevlumab administered by intravenous … [Read more]